Morellic Acid B Overcomes P -Glycoprotein-Mediated Multidrug Resistance in Hepatocellular Carcinoma Cells via Regulation of MAPK/NF-kB Signaling Pathways
ACS Omega · 03.06.2025 · 10 (21) · 21120-21127
DOI: 10.1021/acsomega.4c09692 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 22.05.2025. Verfasst von Xue-Ni Cai und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical Medical School of Guangzhou University of Chinese Medicine, Guangz…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: State Key Laboratory of Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine.
Abstract (Originalsprache)
Multidrug resistance (MDR) is a major clinical obstacle to chemotherapy. The discovery of promising MDR sensitizers is now focused on new, nontoxic, and more efficient P-glycoprotein (P-gp) inhibitors from natural products. In this study, we investigated the MDR-reversing effects of morellic acid B (MAB), a xanthonoid isolated from gamboge, in the doxorubicin (DOX)-resistant human hepatoma cell line BEL-7402/Adr with verapamil as a positive control. Moreover, the function and expression of P-gp, as well as the anti-MDR mechanism, were explored. MAB antagonized the resistance and boosted the cell apoptosis induced by DOX significantly in BEL-7402/Adr cells compared to sensitive cells. Increased intracellular accumulation of DOX and rhodamine 123 by MAB indicated that MAB inhibited the efflux mediated by P-gp. Notably, we found that MAB markedly reduced the expression of P-gp in a concentration-dependent manner in the resistance BEL-7402/Adr cells, but not for sensitive BEL-7402 cells. Moreover, MAB inhibited the NF-κB and phosphorylation of P-p38 MAPK expressions. Collectively, MAB overcomes the P-gp-mediated drug resistance to DOX in B-7402/Adr by inhibiting the function and expression of P-gp, which may relate to its modulating effects on the NF-κB and p38 MAPK signaling pathways. Suggests that MAB has the potential to be a reversal agent for overcoming drug-resistant tumors.
Autor:innen und Institutionen
- State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical Medical School of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China.
- Chinese Medicine Guangdong Laboratory (Hengqin Laboratory), Hengqin, Guangdong 510006, China.
- State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, Taipa 999078, China.
- Department of Hematology, Shunde hospital of Guangzhou university of Chinese traditional medicine, Shunde 528300 P.R. China.
ORCID-Profile: Xue-Ni Cai
Förderung
- State Key Laboratory of Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine
Zitieren
APA
Cai, X. N., Chen, Q., Liu, R. M., Lan, H., & Xie, Y. (2025). Morellic Acid B Overcomes P -Glycoprotein-Mediated Multidrug Resistance in Hepatocellular Carcinoma Cells via Regulation of MAPK/NF-kB Signaling Pathways. ACS Omega, 10(21), 21120-21127. https://doi.org/10.1021/acsomega.4c09692
Vancouver
Cai XN, Chen Q, Liu RM, Lan H, Xie Y. Morellic Acid B Overcomes P -Glycoprotein-Mediated Multidrug Resistance in Hepatocellular Carcinoma Cells via Regulation of MAPK/NF-kB Signaling Pathways. ACS Omega. 2025;10(21):21120-21127. doi:10.1021/acsomega.4c09692
BibTeX
@article{Cai2025,
author = {Cai, Xue-Ni and Chen, Qi and Liu, Rui-Ming and Lan, Hai and Xie, Ying},
title = {Morellic Acid B Overcomes P -Glycoprotein-Mediated Multidrug Resistance in Hepatocellular Carcinoma Cells via Regulation of MAPK/NF-kB Signaling Pathways},
journal = {ACS Omega},
year = {2025},
volume = {10},
number = {21},
pages = {21120--21127},
doi = {10.1021/acsomega.4c09692}
}
EUVIMED